In contrast, Ross et al.44 showed that the most frequent genomic alteration was in P53 (55%) followed by Breast Cancer susceptibility gene (BRCA2) (6%), after comprehensive genomic profiling of 200 patients with CUP. The gene discussed is BRCA2; the disease is breast carcinoma.